| Literature DB >> 35498979 |
Xiong Gao1, Ranhua Zeng2, Chi-Tang Ho3, Bin Li2,4, Shaodan Chen1, Chun Xiao1, Huiping Hu1, Manjun Cai1, Zhongzheng Chen2,4, Yizhen Xie1,5, Qingping Wu1.
Abstract
A water-soluble heteropolysaccharide (SGP2-1) was purified from Suillus granulatus fruiting bodies by anion-exchange chromatography and gel permeation chromatography. The structural characteristics were analyzed by high-performance gel permeation chromatography, high-performance liquid chromatography, Fourier transform infrared spectroscopy, gas chromatography-mass spectrometry, and nuclear magnetic resonance spectroscopy. The immunostimulatory activity was investigated using RAW 264.7 macrophages. Results showed that SGP2-1 with weight average molecular weight of 150.75 kDa was composed of mannose, glucose, and xylose. The backbone of SGP2-1 was mainly composed of → 4)-α-Glcp-(1→, and the terminal group α-d-Glcp → was linked to the main chain by O-6 position. SGP2-1 could significantly enhance pinocytic capacity, reactive oxygen species production, and cytokines secretion. SGP2-1 exerted immunomodulatory effects through interacting with toll-like receptor 2, and activating mitogen-activated protein kinase, phosphatidylinositol-3-kinase/protein kinase B, and nuclear factor-kappa B signaling pathways. These findings indicated that SGP2-1 could be explored as a potential immunomodulatory agent for application in functional foods.Entities:
Keywords: 1H-1H COSY, 1H-1H correlation spectroscopy; ANOVA, Analysis of variance; Akt, Protein kinase B; CCK-8, Cell counting kit-8; D2O, Deuterium oxide; DCFH-DA, 2′,7′-Dichlorofluorescein diacetate; DEPT, Distortionless enhancement by polarization transfer; DMEM, Dulbecco’s modified Eagle’s medium; DPBS, Dulbecco’s phosphate-buffered saline; ELISA, Enzyme-linked immunosorbent assay; ERK, Extracellular signal-regulated kinase; FT-IR, Fourier transform infrared spectroscopy; GC-MS, Gas chromatography-mass spectrometry; HMBC, Heteronuclear multiple bond correlation; HPGPC, High-performance gel permeation chromatography; HPLC, High performance liquid chromatography; HSQC, Heteronuclear single quantum correlation; Heteropolysaccharide; IL-6, Interleukin-6; Immunomodulatory activity; IκBα, I kappa B alpha; JNK, c-Jun N-terminal kinase; LPS, Lipopolysaccharides; MAPKs, Mitogen-activated protein kinase; MCP-1, Monocyte chemoattractant protein-1; Mw, Weight average molecular weight; NF-κB, Nuclear factor-kappa B; NMR, Nuclear magnetic resonance; NO, Nitric oxide; PI3K, Phosphatidylinositol-3-kinase; PMP, 1-Phenyl-3-methyl-5-pyrazolone; RIPA, Radioimmunoprecipitation assay; ROS, Reactive oxygen species; RT-PCR, Reverse transcription-polymerase chain reaction; Structural characterization; Suillus granulatus; TLR2, Toll-like receptor 2; TLR4, Toll-like receptor 4; TNF-α, Tumor necrosis factor-α; iNOS, Inducible nitric oxide synthase
Year: 2022 PMID: 35498979 PMCID: PMC9039890 DOI: 10.1016/j.fochx.2022.100211
Source DB: PubMed Journal: Food Chem X ISSN: 2590-1575
Fig. 1Stepwise elution profile of SGP2-1 on a DEAE-Sepharose fast flow column (A); Elution profile of SGP2 on a Sephacryl S-300 HR column (B); UV–visible spectrum of SGP2-1 (C); HPGPC chromatogram of SGP2-1 (D); Monosaccharide composition of SGP2-1 analyzed by HPLC (1-mannose, 2-ribose, 3-rhamnose, 4-glucuronic acid, 5-galacturonic acid, 6-glucose, 7-galactose, 8-xylose, 9-arabinose, and 10-fucose) (E); FT-IR spectrum of SGP2-1 (F).
Methylation analysis of SGP2-1 by GC-MS.
| Methylated sugar | Linkage pattern | Molar ratios | Mass fragments ( |
|---|---|---|---|
| 2,3,4-Me3-Xyl | 2.6 | 43,71,87,101,117,129,131,161 | |
| 2,3,4,6-Me4-Glc | 17.7 | 43,71,87,101,117,129,145,161,205 | |
| 2,3,6-Me3-Glc | →4)-Glc | 58.8 | 43,87,99,101,113,117,129,131,161,173,233 |
| 2,4,6-Me3-Man | →3)-Man | 6.4 | 43,71,85,87,99,101,117,129,161,201,233 |
| 4,6-Me2-Man | →2,3)-Man | 2.9 | 43,85,87,99,101,127,129,161,201,261 |
| 2,3-Me2-Glc | →4,6)-Glc | 11.6 | 43,71,85,87,99,101,117,127,159,161,201 |
Fig. 213C NMR (A), 1H NMR (B), 1H–1H COSY (C), HSQC (D), and HMBC (E) spectra of SGP2-1, and the main backbone of SGP2-1 (F).
Fig. 3Effect of SGP2-1 on the proliferation of RAW 264.7 cells (A); Effect of SGP2-1 on the pinocytic capacity of neutral red (B); Effect of SGP2-1 on ROS generation in RAW 264.7 cells analyzed by flow cytometry (C) and fluorescence microscope (D).
Fig. 4Effects of SGP2-1 on the secretion of NO (A), TNF-α (B), IL-6 (C), and MCP-1 (D) in the cell culture supernatants and the mRNA expression of iNOS (E), TNF-α (F), IL-6 (G), and MCP-1 (H) in RAW 264.7 macrophages.
Fig. 5Effects of SGP2-1 on MAPKs (A), PI3K/Akt (B), and NF-κB (C) signaling pathways in RAW 264.7 cells; Effects of SP600125, U0126, SB203580, LY294002, and BAY 11-7082 on NO (D), TNF-α (E), and IL-6 (F) secretion in RAW 264.7 cells induced by SGP2-1. **p < 0.01 indicates significant difference from the group treated with SGP2-1 (320 μg/mL) only.